Mellozzan

Melatonin, the active ingredient in Mellozzan, is a melatonin receptor agonist presented as an oral tablet for oral use. It helps regulate the sleep‑wake cycle and is used to promote sleep onset in adults with sleep disturbances, and is commonly employed in the management of transient insomnia, jet lag, and shift‑work related sleep disruption.

GNH USA supplies Mellozzan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide across multiple regulatory jurisdictions and health‑care institutions, ensuring consistent quality.

Mellozzan (melatonin) acts on the melatonin receptor pathway to support normal sleep regulation.

Insomnia: reduces sleep onset latency and improves total sleep time in adults with transient insomnia. Jet lag: facilitates adjustment of the circadian rhythm after rapid time‑zone travel. Shift work disorder: helps align sleep patterns for individuals working non‑standard hours.

Mellozzan may be associated with several adverse reactions, most of which are mild and transient.

Common Side Effects: - Headache: mild to moderate headache reported. - Dizziness: occasional sensation of light‑headedness. - Daytime sleepiness: residual drowsiness after dosing. - Nausea: mild gastrointestinal upset. - Irritability: transient mood changes.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or anaphylaxis. - Severe depression: worsening mood or depressive symptoms. - Seizures: rare occurrence of convulsive episodes.

Before using Mellozzan, consider the following precautions to ensure safe and effective use.

- Assess indication: confirm that the sleep disturbance is appropriate for melatonin therapy. - Review medications: evaluate potential interactions with anticoagulants, CNS depressants, or immunosuppressants. - Monitor drowsiness: advise patients to avoid operating machinery or driving if residual sleepiness occurs. - Use in special populations: exercise caution in children, elderly, and pregnant or breastfeeding individuals. - Discontinue if allergic: stop the product immediately if signs of hypersensitivity develop. - Store at ambient temperature: keep below 25 °C in the original container, protected from moisture and direct sunlight.

Melatonin can interact with other medicines; the following interactions are recognized.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): melatonin may increase bleeding risk; concurrent use should be avoided. - Central nervous system depressants (e.g., benzodiazepines, barbiturates): combined use can enhance sedation and impair psychomotor performance.

Moderate Interactions (Monitor Closely): - Immunosuppressants (e.g., cyclosporine): melatonin may alter immune response; monitor therapeutic levels. - Antidiabetic agents: melatonin can affect glucose metabolism; check blood sugar regularly. - Oral contraceptives: melatonin may increase plasma concentrations; observe for hormonal side effects.